Pharmaceuticals & Biotech

Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.

  • 7 Subtopics
  • 9 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

Inside Pharmaceuticals & Biotech

Discovery & Preclinical Targets, assays, animal models, and early safety/tox studies before human trials. Clinical Trials (Phases I–IV) Design, endpoints, enrollment, interim reads, and post‑market surveillance. Approvals, Safety & REMS FDA/EMA decisions, boxed warnings, pharmacovigilance, and label changes. Generics & Biosimilars Access, interchangeability, litigation, and pricing dynamics for follow‑ons. Vaccines & Immunization Platforms (mRNA, viral vector), boosters, schedules, and cold‑chain supply. Cell & Gene Therapies CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up. Manufacturing & Supply APIs, sterile fill‑finish, shortages, and quality systems across the supply chain.

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Pharmaceuticals & Biotech


univest.in > blogs > biocon-share-price-pertuzumab-biosimilar-ema-chmp-approval

Biocon Share Price on Pertuzumab EMA Approval

9+ hour, 27+ min ago   (617+ words) Biocon Biologic’s Pertuzumab biosimilar (Pebrilzo, 420mg) gets positive CHMP opinion from EMA, first biosimilar of its kind to do so. For HER2-positive breast cancer, multiple disease stages. Biocon share price is set to be in focus after the company’s wholly-owned subsidiary…...


nature.com > collections > fjbhbgcigc > how-to-submit

How to submit | Genetic Medicines: From Genomic Discovery to Clinical Translation

1+ day, 3+ hour ago   (194+ words) This Collection supports and amplifies research related to SDG 3: Good Health & Wellbeing. This Collection will explore the development and clinical translation of genetic medicines, spanning the journey from genomic discovery to therapeutic development and patient care. We welcome original research…...


ctvnews.ca > calgary > article > outdated-health-policies-surrounding-covid-still-pose-a-danger-today-says-u-of-c-researcher

‘Outdated’ health policies surrounding Covid still pose a danger today, says U of C researcher

1+ day, 22+ hour ago   (734+ words) CTV News...


pharmabiz.com > NewsDetails.aspx

Flow Neuroscience launches FL-100 in US; first US FDA-approved at-home tDCS treatment for depression

2+ day, 9+ hour ago   (84+ words) Malmö, Sweden Saturday, September 19, 2026, 16:00 Hrs [IST] Flow Neuroscienc... Flow Neuroscience launches FL-100 in US; first US FDA-approved at-home tDCS treatment for depression Flow Neuroscience, a global company developing new generation of electronic medicine for mental health, announced that FL-100 is…...


newswise.com > articles > from-glp-1s-to-gene-therapy-ent-s-next-breakthroughs-take-center-stage-in-los-angeles

From GLP-1s to Gene Therapy: ENT’s Next Breakthroughs Take Center Stage in Los Angeles | Newswise

4+ day, 4+ hour ago   (471+ words) Newswise — ALEXANDRIA, Va.— The latest treatments and research advances in ear, nose, and throat care will take center stage in Los Angeles October 17-20, when more than 5,000 of the world’s leading otolaryngologists gather for the 2026 Annual Meeting & OTO EXPO of the…...


foxnews.com > video > 6405155171112

RFK Jr., Gov Shapiro clash over Pennsylvania measles outbreak | Fox News Video

4+ day, 18+ hour ago   (17+ words) Fox News contributor Dr. Stephanie Widmer discusses measles transmission rates and synthetic opioid risks on 'America's Newsroom.'...


foxnews.com > video > 6405151041112

Trump surgeon general nominee Saphier backs MMR, hepatitis B vaccines in Senate hearing | Fox News Video

4+ day, 18+ hour ago   (73+ words) Nicole Saphier, MD, said she does not believe childhood vaccines cause autism and called the MMR vaccine the “greatest tool for combatting measles” during questioning from Sen. Bill Cassidy, R-La. Trump surgeon general nominee Saphier backs MMR, hepatitis B vaccines…...


plexusdx.com > blogs > learn > emerge-weight-loss-pricing-dose-tiered-costs-long-term-treatment-plexusdx

Emerge Weight Loss Pricing: Dose Costs and Long-Term Treatment Plans – PlexusDx

5+ day, 22+ hour ago   (1235+ words) Shop all 5 Weight Loss programs → Compare GLP-1 providers → Start Weight Loss intake → Shop all 5 Longevity programs → Start Longevity intake → GLP-1 & Peptide Pathways Food Sensitivity & Allergies Diet & Weight Loss Cognition and Brain Health Genetic Test Stress and Mental Health Genetic Test…...


newswise.com > articles > unc-lineberger-secures-40m-from-openai-foundation-to-make-cancer-vaccines-more-effective

UNC Lineberger Secures $40M from OpenAI Foundation to Make Cancer Vaccines More Effective

6+ day, 11+ hour ago   (407+ words) CHAPEL HILL, N.C., Sept. 15, 2026 – UNC Lineberger Comprehensive Cancer Center has received $40 million from the OpenAI Foundation, the non-profit parent organization that governs the for-profit company OpenAI Group PBC, to generate data that could make personalized cancer vaccines more effective. Cancer vaccines…...


plexusdx.com > blogs > learn > best-rex-md-alternatives-glp1-treatment-2026-plexusdx

Best Rex MD Alternatives for GLP-1 Weight Loss in 2026 — 2026

6+ day, 14+ hour ago   (1126+ words) Shop all 5 Weight Loss programs → Compare GLP-1 providers → Start Weight Loss intake → Shop all 5 Longevity programs → Start Longevity intake → GLP-1 & Peptide Pathways Food Sensitivity & Allergies Diet & Weight Loss Cognition and Brain Health Genetic Test Stress and Mental Health Genetic Test…...